- Home
- Products
Tepmetko (Tepotinib)
Tepmetko (Tepotinib)
- Medicine Name: Tepmetko
- Generic Name: Tepotinib
- Dosage Form & Strength: Tablets – 225 mg
- Manufactured By: EMD Serono, Inc.
Tepmetko is a kinase inhibitor approved for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping alterations, as confirmed by an FDA-approved test.
Recommended Dosage:
- 450 mg once daily (2 × 225 mg tablets) with food
- Take at the same time daily
- Do not crush, chew, or split the tablets
- If vomiting occurs, skip the dose and resume the next scheduled dose
- Skip any missed dose if it’s less than 8 hours from the next one
Interstitial Lung Disease (ILD)/Pneumonitis: Can be fatal. Monitor for respiratory symptoms and promptly assess any new/worsening cough, dyspnea, or fever.
Liver Toxicity: Monitor liver enzymes (ALT, AST, bilirubin) before and regularly during treatment. Interrupt dose if elevated.
Fetal Harm Risk: May harm an unborn baby. Use effective contraception during treatment and for 1 week after the last dose.
Breastfeeding: Not recommended during and for 1 week after final dose due to potential risk to the infant.
Drug Interactions: Inform your doctor of all other medications, including OTC and herbal supplements.
Required Documents to Import Tepmetko to India:
- Valid prescription from a qualified oncologist
- Diagnostic reports confirming MET exon 14 skipping mutation
- Government-issued photo ID of the patient
Order Confirmation:
- Confirmed upon receipt of documents and import permit, if applicable
Availability in India & Globally: Available in Mumbai, Delhi, Hyderabad, Chennai, Bangalore, Kolkata, Ahmedabad, Pune, and all major cities. Also available for export under Named Patient Program.
To Order or Enquire Price:
- 📞 WhatsApp/Call: +91-99675 15602
- 📧 Email: info@globalraremeds.com
Global Rare Meds sources Tepmetko from certified suppliers in the USA, Europe, Canada, and Australia. Each order is:
- Verified by licensed pharmacists
- Shipped securely from our fulfillment center in Ambernath, Thane District
- Compliant with all legal and regulatory standards
We ensure global delivery, quality assurance, and complete transparency.
What is the generic name of Tepmetko®?
Tepotinib
Who manufactures Tepmetko®?
EMD Serono, Inc.
Is Tepmetko® FDA approved?
Yes. Approved on February 3, 2021
What strength is Tepmetko® supplied in?
Tablets: 225 mg
How is Tepmetko® administered?
Orally, once daily with food. Do not chew or break the tablet.
Common side effects?
Nausea, edema, fatigue, diarrhea, musculoskeletal pain, and breathlessness
What is the price of Tepmetko® in India?
Price may vary. For up-to-date pricing, WhatsApp +91-99675 15602 or email info@globalraremeds.com
Storage conditions?
Store at 20°C to 25°C, excursions permitted between 15°C and 30°C. Keep in original packaging.
Is it safe to buy Tepmetko® online in India?
Yes. Tepmetko can be legally and safely ordered from Global Rare Meds under the Named Patient Import Program
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
